Yalcin-Ülker, G. M. Et Al. 2023. Could Local Application of Hypoxia Inducible Factor 1-α Enhancer Deferoxamine Be Promising for Preventing of Medication-Related Osteonecrosis of the Jaw?. Biomedicines , vol.11, no.3 .

Yalcin-Ülker, G. M., Günbatan, M., Duygu, G., SOLUK TEKKEŞİN, M., & Özcakir-Tomruk, C., (2023). Could Local Application of Hypoxia Inducible Factor 1-α Enhancer Deferoxamine Be Promising for Preventing of Medication-Related Osteonecrosis of the Jaw?. Biomedicines , vol.11, no.3.

Yalcin-Ülker, Gül Et Al. "Could Local Application of Hypoxia Inducible Factor 1-α Enhancer Deferoxamine Be Promising for Preventing of Medication-Related Osteonecrosis of the Jaw?," Biomedicines , vol.11, no.3, 2023

Yalcin-Ülker, Gül M. Et Al. "Could Local Application of Hypoxia Inducible Factor 1-α Enhancer Deferoxamine Be Promising for Preventing of Medication-Related Osteonecrosis of the Jaw?." Biomedicines , vol.11, no.3, 2023

Yalcin-Ülker, G. M. Et Al. (2023) . "Could Local Application of Hypoxia Inducible Factor 1-α Enhancer Deferoxamine Be Promising for Preventing of Medication-Related Osteonecrosis of the Jaw?." Biomedicines , vol.11, no.3.

@article{article, author={Gül Merve Yalcin-Ülker Et Al. }, title={Could Local Application of Hypoxia Inducible Factor 1-α Enhancer Deferoxamine Be Promising for Preventing of Medication-Related Osteonecrosis of the Jaw?}, journal={Biomedicines}, year=2023}